Overview
Evidence-based recommendations on Kinesia 360 and KinesiaU (Great Lakes NeuroTechnologies), PDMonitor (PD Neurotechnology), Personal KinetiGraph (Global Kinetics) and STAT‑ON (Sense4care) for remote monitoring of Parkinson’s disease.
Last reviewed: 25 January 2024
NICE has developed tools and resources, in association with relevant stakeholders, to help organisations put this guidance into practice, including an evidence generation plan. The evidence generation plan gives further information on the prioritised evidence gaps and outcomes, ongoing studies and potential real-world data sources. It includes how the evidence gaps could be resolved through real-world evidence studies.
This guidance replaces NICE’s medtech innovation briefing on Personal KinetiGraph for remote clinical management of Parkinson's disease (MIB258).
Diagnostics guidance 51 has been migrated to HealthTech guidance 657.
Next review: This guidance will be reviewed if there is new evidence that is likely to change the recommendations.